Periodic Reporting for period 3 - UNITE4TB (ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS)

The UNITE4TB consortium aims to accelerate and improve the clinical evaluation of novel compounds and combinations of drugs to develop new and highly active anti-tuberculosis (TB) treatment regimens for drug-resistant (DR) and drug-sensitive (DS) TB. Together with EFPIA and...